Fridley-based Medtronic will be getting $17 million over the next three years for an initiative aimed at stabilizing blood sugar levels in diabetics. The medical technology company announced Friday that they are getting the money from the Juvenile Diabetes Research Foundation and the Helmsley Charitable Trust to improve existing and develop new artificial pancreas technology.
Minneapolis rolls out new crime-reducing plan, but provides little detail
"Operation Endeavor" is a collaboration between multiple agencies.
Walz hopes for investigation into judge in Feeding Our Future case
The governor said he was "speechless" by the judge's initial decision.
Commuter alert: Parking in Minneapolis just got cheaper!
FlexPass offers flexible parking downtown at Ramp A
Omicron subvariants BA.4.6, BA.2.75.2 drawing attention in MN
Health officials in Minnesota are paying special attention to BA.4.6.
Texas company buys Roseville's Har Mar Mall for $50 million
The mall is home to a Cub Foods and a Burlington, among other stores.
Nightmare traffic near Ren Fest causes headache for businesses
The festival runs through Oct. 2.
Increased state police presence in Twin Cities to stay till year's end
Topics included HEAT patrols, violent crime, fentanyl and street racing.
Vegan East sign goes up at former QC Pizza spot in Minneapolis
Vegan baked goods appear to be on the horizon in the Southside.
Minnesota's COVID-19 update for the week ending Tuesday, Sept. 20
The amount of COVID detected in wastewater jumped, as did hospitalizations.
Police: Armed trio broke into Brooklyn Park apartment
The trio asked a resident if a family member was home.
Medtronic to study device that could lead to artificial pancreas for diabetics
Medtronic has a green light from regulators to begin studies that could lead to automated insulin delivery. A feature in the company's insulin pumps stops sending insulin when blood sugar levels get too low.
Is Medtronic going after India's largest med-tech company?
A respected Indian business publication is reporting that Medtronic is negotiating with an Indian medical technology company to make a strategic investment in it. Trivitron Healthcare is reportedly India’s largest med tech company. The Fridley-based company has not commented specifically on the deal, however, CEO Omar Ishrak has made no secrets about his interest in India.
CEO: Medtronic's focus paying off
After a solid last year and last quarter, Medtronic Inc. CEO Omar Ishrak is reiterating that his company's commitment is to growth through globalization, innovation and enhancing value, not just creating new medical technology products. It's what Ishrak has consistently preached in the year-plus since he took the helm at the world's largest medical device company.
Medtronic cutting 1,000 jobs despite growing profits
The Fridley-based medical device maker plans to eliminate positions in facilities around the globe, including 220 positions at its Mounds View-based division. Medtronic topped expectations in the fourth quarter, but continues to struggle with the sale of heart rhythm devices as well as devices used in spine surgery.
Medtronic workers in India mentor Minn. high school students
It's not unusual for Minnesota-company professionals mentoring high school students. So it was this past spring with Fridley-based Medtronic Inc. and students at Buffalo High School. But there was a twist. The Medtronic employees mentoring Brenda Diekman's accounting class weren't local. They are halfway around the world – in Mumbai, India.
Medical alert issued for Medtronic's Entrust defibrillators
British regulators warn the device has a battery defect that can fail to properly shock a heart back into a normal rhythm. Patients are encouraged to see their cardiologists to ensure an audible "low-battery" alert is working properly. Fridley-based Medtronic denied any wrong doing, but settled lawsuits regarding battery issues in its Marquis line of defibrillators less than four years ago.
Feds close probe into Medtronic's marketing of its Infuse bone graft product
The U.S. Department of Justice spent four years looking into whether the Fridley-based manufacturer encouraged doctors to use the product in ways not described on the FDA-approved label. Medtronic denies any wrongdoing, but still faces civil lawsuits and agreed to pay $85 million in March to settle a federal securities lawsuit.
You Can Get BMTN Special Offers!